Karachi: In a significant financial event, BF Biosciences Limited (BFBIO), a joint venture between Ferozsons Laboratories Ltd. and Argentina’s Bagó Group, marked its listing on the Pakistan Stock Exchange (PSX) with a gong ceremony, celebrating its successful initial public offering (IPO). This IPO, which garnered substantial investor interest, underscores the robust potential of Pakistan’s biopharmaceutical sector.
According to Pakistan Stock Exchange Limited, the listing event was a highlight in PSX’s recent history, with the IPO achieving an oversubscription of 3.4 times. BF Biosciences raised Rs 1,375,000,000 through the sale of 25,000,000 ordinary shares, with a significant portion initially allocated to institutional bidders and the remainder offered to retail investors through a 100% book-building process. The strike price was established at Rs 77 per share, reflecting strong market confidence in the company’s future.
The ceremony featured notable attendees, including Mr. Osman Khalid Waheed, CEO of Ferozsons Laboratories, Mr. Farhan Rafiq, COO of BF Biosciences, and Mr. Rallys Eduardo Pliauzer, Group Director of Grupo Empresarial Bagó, alongside the Argentine Ambassador to Pakistan, Mr. Sebastian Sayus. Senior executives from PSX and Arif Habib Limited, the lead manager to the issue, were also present.
BF Biosciences, recognized for its pioneering role in biotech pharmaceuticals, especially during the COVID-19 pandemic, has expanded its product portfolio to include essential drugs for diseases like cancer, chronic kidney disease, and hepatitis C. The company’s significant contributions also extend to manufacturing critical biological medicines locally, substantially reducing treatment costs in Pakistan.
The successful IPO and the subsequent listing event highlight BF Biosciences’ commitment to advancing healthcare through innovation and strategic international collaborations. This venture not only enhances the local pharmaceutical landscape but also positions the company as a key player in the global biotech industry.